Gelonghui, May 7, 丨 Nanxin Pharmaceutical (688189.SH) announced that in April 2024, the company did not repurchase shares. As of April 30, 2024, the company has repurchased a total of 1,228,955 shares through the Shanghai Stock Exchange trading system, accounting for 0.4479% of the company's total share capital of 274,400,000 shares. The highest price of the repurchase transaction was 9.24 yuan/share, the lowest price was 5.45 yuan/share, and the total capital paid was RMB 7,997,384.37 (excluding transaction fees such as stamp duty and transaction commissions).
南新制药(688189.SH)：4月公司未回购股份
Nanxin Pharmaceutical (688189.SH): The company did not repurchase shares in April
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.